Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ortivus AB's Enterprise Value is kr192.36 Mil.
Ortivus AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr-18.43 Mil. Therefore, Ortivus AB's EV-to-EBIT ratio for today is -10.44.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ortivus AB's Enterprise Value is kr192.36 Mil.
Ortivus AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-18.43 Mil. Therefore, Ortivus AB's EV-to-EBITDA ratio for today is -10.44.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ortivus AB's Enterprise Value is kr192.36 Mil.
Ortivus AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was kr76.75 Mil. Therefore, Ortivus AB's EV-to-Revenue ratio for today is 2.51.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Ortivus AB's Enterprise Value is kr192.36 Mil.
Ortivus AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-27.73 Mil. Therefore, Ortivus AB's EV-to-FCF ratio for today is -6.94.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Ortivus AB (OSTO:ORTI A) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ortivus AB's current Enterprise Value is kr192.36 Mil.
Ortivus AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-18.43 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ortivus AB's current Enterprise Value is kr192.36 Mil.
Ortivus AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-18.43 Mil.
Ortivus AB's current Enterprise Value is kr192.36 Mil.
Ortivus AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr76.75 Mil.
Ortivus AB's current Enterprise Value is kr192.36 Mil.
Ortivus AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-27.73 Mil.
Ortivus AB's current Enterprise Value is kr192.36 Mil.
Ortivus AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-27.73 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ortivus AB Enterprise Value Related Terms
Ortivus AB Enterprise Value Historical Data
* Premium members only.
The historical data trend for Ortivus AB's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ORTI A vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Ortivus AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ortivus AB Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ortivus AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ortivus AB's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ortivus AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of kr192.36 Mil mean?
Ortivus AB (OSTO:ORTI A) has a Enterprise Value of kr192.36 Mil as of Aug. 20, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ortivus AB and its competitors.
Is Ortivus AB's Enterprise Value too high?
Ortivus AB's current Enterprise Value is kr192.36 Mil. Overall, Ortivus AB has a GF Score™ of 44/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ortivus AB's Enterprise Value compare to ISRG and BDX?
Ortivus AB's Enterprise Value of kr192.36 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ortivus AB and its competitors. Ortivus AB's current Enterprise Value is kr192.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ortivus AB stock overvalued right now?
Based on GuruFocus' analysis, Ortivus AB (OSTO:ORTI A) is currently considered Fairly Valued. The stock's GF Value™ is kr2.44, compared to a current price of kr2.36 — trading 3.3% below its estimated fair value. The current Enterprise Value is kr192.36 Mil. Ortivus AB's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Ortivus AB (OSTO:ORTI A), the current Enterprise Value is kr192.36 Mil as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ortivus AB (OSTO:ORTI A) Overvalued in 2026?
Based on GuruFocus' analysis, Ortivus AB stock appears to be undervalued.
The current stock price of kr2.36 is trading 3.3% below its estimated GF Value™ of kr2.44.
GuruFocus considers Ortivus AB to be Fairly Valued.
Key valuation signals for OSTO:ORTI A:
Enterprise Value: kr192.36 Mil
GF Value™: kr2.44 vs. price of kr2.36 (3.3% below fair value)
No single metric tells the full story. See the OSTO:ORTI A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ortivus AB is a supplier of mobile solutions for modern emergency medical care. The company has developed an user-friendly solutions that supports diagnostics, increase efficiency, and deliver long-term cost savings for healthcare providers. By integrating its solutions with electronic health records, dispatch systems, and national registries, the company ensures fast and secure information management and more integrated care process. Its product portfolio includes MobiMed ePR, MobiMed Monitor, MobiMed FleetCtrl, MobiMed Life, and others.
44GF Score
Get the complete analysis for OSTO:ORTI A
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ORTI A has been successfully added to your 
